We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GNPX market cap is 5.19M. The company's latest EPS is USD -3.6271 and P/E is -0.17.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.78M | -5.99M | -6M | -6.52M | -4.32M |
| Net Income | -7.75M | -5.93M | -5.97M | -6.5M | -4.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.68M | -17.96M | -19.6M | -23.83M | -31.08M |
| Net Income | -10.66M | -17.94M | -19.6M | -23.74M | -30.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.64M | 10.67M | 12.56M | 6.61M | 3.91M |
| Total Liabilities | 4.34M | 3.26M | 3.81M | 2.26M | 2.24M |
| Total Equity | 12.31M | 7.42M | 8.76M | 4.35M | 1.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.53M | 31.37M | 42.86M | 25.09M | 10.67M |
| Total Liabilities | 510k | 451k | 1.59M | 2.81M | 3.26M |
| Total Equity | 3.02M | 30.92M | 41.28M | 22.28M | 7.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.78M | -24.74M | -5.3M | -11.09M | -13.28M |
| Investing | -61k | -71k | -16k | 1,000 | 1,000 |
| Financing | 10.59M | 10.59M | 6.79M | 6.81M | 8.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.92M | -13.94M | -14.29M | -17.78M | -24.74M |
| Investing | -947k | -2.34M | -84k | 97k | -71k |
| Financing | 1.27M | 41.59M | 25.68M | 7k | 10.59M |
| Market Cap | 5.19M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.78 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | - |
| Shares Outstanding | 8.51M |
| Average Volume (1 week) | 206.78k |
| Average Volume (1 Month) | 286.97k |
| 52 Week Change | -92.77% |
| 52 Week High | 9.26 |
| 52 Week Low | 0.2806 |
| Spread (Intraday) | 1.46 (72.28%) |
| Company Name | Genprex Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.genprex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
